Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
      QxMD      Google Scholar   
Citation:
Nat Commun vol 12
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24C196171, W81XWH-18-1-0034, W81XWH-18-1-0040, W81XWH-18-1-0035, and W81XWH-18-1-0084 K22 CA229613, CCR1854815, CCR16380599, PG12220321, RR140033 to MJE  
Corr. Author:
 
Authors:
                       
Networks:
LAPS-MO011, OK037, TX041   
Study
ACOSOG-Z1031
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Cancer therapy, DNA damage and repair